• Krishnan Chakravarthy, Natalie Strand, Anne Frosch, Dawood Sayed, Lakshmi Rekha Narra, Rahul Chaturvedi, Prabhdeep K Grewal, Jason Pope, Michael E Schatman, and Timothy Deer.
• Department of Anesthesiology and Pain Medicine, University of California San Diego Health Sciences, San Diego, CA, USA.
• J Pain Res. 2021 Jan 1; 14: 623-629.

AbstractTo date, COVID-19 has spread to more than 108 million people globally, with a death toll surpassing 2 1/2 million. With the United States Food and Drug Administration (FDA) approval of two highly effective COVID-19 vaccines from Pfizer-BioNtech and Moderna, we now have a novel approach to contain COVID-19 related morbidity and mortality. Chronic pain care has faced unprecedented challenges for patients and providers in this ever-changing climate. With the approval of COVID-19 vaccines, we now face questions relating to the potential effects of pain treatments utilizing steroids on vaccine efficacy. In this analysis, we address these issues and provide guidance for steroid therapies based on available data and expert recommendations.© 2021 Chakravarthy et al.

5 keywords...

hide…